4th Quarter - Report — ENDO INTERNATIONAL for ENDO INTERNATIONAL (2011)

Firm

ENDO INTERNATIONAL

Client

ENDO INTERNATIONAL

Income

—

Expenses

$700,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Life Sciences Jobs and Investment Act (H.R. 2632, S. 1410)

Lobbyist	Covered position, as disclosed
BRENT J FISK	—
JAMES BRIAN MUNROE	—
CANDIE PHIPPS New	—

Contacted: SENATE; Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2632 (112th), S. 1410 (112th)

Copyright/Patent/Trademark CPT

Patent reform issues (H.R. 1249, S. 23); Pattent settlements (S. 27).

Lobbyist	Covered position, as disclosed
BRENT J FISK	—
JAMES BRIAN MUNROE	—
CANDIE PHIPPS New	—

Contacted: HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); SENATE

Bills named: S. 23 (112th), S. 27 (112th), H.R. 1249 (112th)

Health Issues HCR

Drug reimportation issues (S. 319); Reauthorization of Prescription Drug User Fee Act; Life sciences research tax credit legislation (Life Sciences Jobs and Investment Act--H.R.2632, S. 1410); Healthcare reform bill repeal (H.R. 2); Preserving Access to Orphan Drus Act of 2011 (H.R. 2672, S. 1423); Medicare rebates and reimbursement rates; 340B drug discount program (340B Program Improvement Act--H.R. 2674)

Lobbyist	Covered position, as disclosed
BRENT J FISK	—
JAMES BRIAN MUNROE	—
CANDIE PHIPPS New	—

Contacted: HOUSE OF REPRESENTATIVES; Drug Enforcement Administration (DEA); SENATE

Bills named: S. 1410 (112th), H.R. 2672 (112th), H.R. 2674 (112th), H.R. 2632 (112th), S. 1423 (112th), H.R. 2 (112th), S. 319 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.